Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors
Matthew S. Bramble(Children's National), Anne W. Rimoin(University of California, Los Angeles), D’Andre Spencer(University of California, Los Angeles), Peter B. Jahrling(National Institutes of Health), Patrick Mukadi(National Institute of Biomedical Research), Pavlo Gilchuk(AstraZeneca (Japan)), Guy Cavet(Itasca Consultants (United States)), James E. Crowe(Vanderbilt University Medical Center), Neerja Vashist(Children's National), Benoit Kebela Illunga(Ministry of Public Health), James Logue(National Institutes of Health), Jonathan Marchand(National Institutes of Health), Justin Varughese(National Institutes of Health), Nicole A. Hoff, Erica Ollmann Saphire(La Jolla Institute for Immunology), Emile Okitolonda Wemakoy(Ministry of Public Health), Graham Simmons(University of California, San Francisco), Cyrus Sinai(University of California, Los Angeles), Gene G. Olinger(Health Affairs), Bradly P. Nicholson(Durham VA Medical Center), Imke Steffen(University of Veterinary Medicine Hannover, Foundation), Lisa Hensely(National Institutes of Health), Reena H. Doshi(Centers for Disease Control and Prevention), Kai Lü(Shanghai University of Traditional Chinese Medicine), Tito Serafini(Itasca Consultants (United States)), Jean Jacques Muyembe-Tamfum(National Institute of Biomedical Research), Éric Vilain(University of California, Irvine), Allen Lipson(University of California, Los Angeles), James Pettitt(National Institutes of Health), Richard S. Bennett(National Institutes of Health)
Cited by 22
Related Papers
An evidence review of face masks against COVID-19
|Proceedings of the National Academy of Sciences|2021|1.3k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
|Proceedings of the National Academy of Sciences|2004|572